A Study of BMS-986484 Alone and Combination Therapy in Participants With Advanced Solid Tumors

This study is testing a new drug called BMS-986484, alone or in combination with other treatments, in people with several types of advanced solid tumors — including lung, pancreatic, stomach, colorectal, and head and neck cancers. **You may be eligible if...** - You have advanced, metastatic, or recurrent non-small cell lung cancer, pancreatic cancer, gastric/gastroesophageal junction cancer, MSS colorectal cancer, or head and neck squamous cell carcinoma - You have measurable tumors on scans - You are in reasonably good physical condition (ECOG 0–1) **You may NOT be eligible if...** - You have active lung scarring or interstitial lung disease - You have an active autoimmune disease - You have serious uncontrolled medical conditions - You have had a recent blood clot Talk to your doctor to see if this trial is right for you.